Evidence for a role of the 5-HT1Breceptor and its adaptor protein, p11, inl-DOPA treatment of an animal model of Parkinsonism
- 12 February 2008
- journal article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 105 (6) , 2163-2168
Abstract
Parkinson's disease (PD) is characterized by a progressive degeneration of substantia nigra dopaminergic neurons projecting to the striatum. Restoration of dopamine transmission byl-DOPA relieves symptoms of PD but causes prominent side effects. There is a strong serotonin innervation of the striatum by serotonergic neurons that remains relatively preserved in PD. The study of this innervation has been largely neglected. Here, we demonstrate that chronicl-DOPA administration to 6-OHDA-lesioned rodents increases, via D1receptors, the levels of the 5-HT1Breceptor and its adaptor protein, p11, in dopamine-denervated striatonigral neurons. Using unilaterally 6-OHDA-lesioned p11 WT and KO mice, it was found that administration of a selective 5-HT1Breceptor agonist, CP94253, inhibitedl-DOPA-induced rotational behavior and abnormal involuntary movements in a p11-dependent manner. These data reveal anl-DOPA-induced negative-feedback mechanism, whereby the serotonin system may influence the symptomatology of Parkinsonism.Keywords
This publication has 36 references indexed in Scilit:
- Preferential loss of serotonin markers in caudate versus putamen in Parkinson's diseaseBrain, 2007
- Critical Involvement of cAMP/DARPP-32 and Extracellular Signal-Regulated Protein Kinase Signaling in L-DOPA-Induced DyskinesiaThe Journal of Neuroscience, 2007
- Alterations in 5-HT 1B Receptor Function by p11 in Depression-Like StatesScience, 2006
- A simple rodent assay for the in vivo identification of agents with potential to reduce levodopa-induced dyskinesia in Parkinson's diseaseExperimental Neurology, 2005
- Parkinson's DiseaseNeuron, 2003
- Loss of bidirectional striatal synaptic plasticity in L-DOPA–induced dyskinesiaNature Neuroscience, 2003
- Striatal fosB Expression Is Causally Linked with l-DOPA-Induced Abnormal Involuntary Movements and the Associated Upregulation of Striatal Prodynorphin mRNA in a Rat Model of Parkinson's DiseaseNeurobiology of Disease, 1999
- L‐DOPA‐induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin‐ and glutamic acid decarboxylase mRNAEuropean Journal of Neuroscience, 1998
- D 1 and D 2 Dopamine Receptor-regulated Gene Expression of Striatonigral and Striatopallidal NeuronsScience, 1990
- ADMINISTRATION OF A PERIPHERAL DECARBOXYLASE INHIBITOR WITH L-DOPA TO DEPRESSED PATIENTSThe Lancet, 1970